Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway

BACKGROUND: Aspirin, as a non-steroidal anti-inflammatory drug, can improve the survival rate of patients with colorectal cancer, while aspirin is effective in patients with PIK3CA mutant colorectal cancer (CRC). However, the mechanism of aspirin in the treatment of PIK3CA mutated CRC patients remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhihang, Wang, Chun, Dong, Hao, Wang, Xing, Gao, Feng, Zhang, Sen, Zhang, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993447/
https://www.ncbi.nlm.nih.gov/pubmed/32000660
http://dx.doi.org/10.1186/s10020-020-0139-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993447/
https://www.ncbi.nlm.nih.gov/pubmed/32000660
http://dx.doi.org/10.1186/s10020-020-0139-5

Ejemplares similares